Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1986 Jun;58(3):869–875. doi: 10.1128/jvi.58.3.869-875.1986

Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies.

J O Fleming, M D Trousdale, F A el-Zaatari, S A Stohlman, L P Weiner
PMCID: PMC252994  PMID: 3701929

Abstract

To analyze the pathogenesis of the neurotropic murine coronavirus JHMV, we used monoclonal antibodies to the E2 viral glycoprotein to select antigenic variant viruses. Monoclonal antibodies J.7.2 and J.2.2 were shown to bind to topographically distinct regions of the E2 molecule, and the variants selected with the two antibodies demonstrated very different disease pictures in mice. Variants selected with J.7.2 were, like the parental virus, highly virulent and caused an acute encephalitic illness. By contrast, J.2.2-selected variants predominantly caused a subacute paralytic disease clinically and extensive demyelination histologically. Antigenic differences among the variants and parental virus were readily demonstrable with anti-E2 monoclonal antibodies. However, no differences between the viruses could be shown in binding studies with monoclonal antibodies directed against either E1 or N, the other two JHMV structural proteins. Since only J.2.2 selected demyelinating variants with reduced neurovirulence, it is likely that this monoclonal antibody recognizes a subregion of the E2 molecule that is particularly important in JHMV pathogenesis.

Full text

PDF
869

Images in this article

872Image
on p.872
873Image
on p.873

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baybutt H. N., Wege H., Carter M. J., ter Meulen V. Adaptation of coronavirus JHM to persistent infection of murine sac(-) cells. J Gen Virol. 1984 May;65(Pt 5):915–924. doi: 10.1099/0022-1317-65-5-915. [DOI] [PubMed] [Google Scholar]
  2. Buchmeier M. J., Lewicki H. A., Talbot P. J., Knobler R. L. Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology. 1984 Jan 30;132(2):261–270. doi: 10.1016/0042-6822(84)90033-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Collins A. R., Knobler R. L., Powell H., Buchmeier M. J. Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell--cell fusion. Virology. 1982 Jun;119(2):358–371. doi: 10.1016/0042-6822(82)90095-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dietzschold B., Wiktor T. J., Trojanowski J. Q., Macfarlan R. I., Wunner W. H., Torres-Anjel M. J., Koprowski H. Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro. J Virol. 1985 Oct;56(1):12–18. doi: 10.1128/jvi.56.1.12-18.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Evans D. M., Minor P. D., Schild G. S., Almond J. W. Critical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3. Nature. 1983 Aug 4;304(5925):459–462. doi: 10.1038/304459a0. [DOI] [PubMed] [Google Scholar]
  6. Fleming J. O., Stohlman S. A., Harmon R. C., Lai M. M., Frelinger J. A., Weiner L. P. Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology. 1983 Dec;131(2):296–307. doi: 10.1016/0042-6822(83)90498-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fleming J. O., Ting J. Y., Stohlman S. A., Weiner L. P. Improvements in obtaining and characterizing mouse cerebrospinal fluid. Application to mouse hepatitis virus-induced encephalomyelitis. J Neuroimmunol. 1983 Apr;4(2):129–140. doi: 10.1016/0165-5728(83)90017-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gonzalez-Scarano F., Janssen R. S., Najjar J. A., Pobjecky N., Nathanson N. An avirulent G1 glycoprotein variant of La Crosse bunyavirus with defective fusion function. J Virol. 1985 Jun;54(3):757–763. doi: 10.1128/jvi.54.3.757-763.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Greenspan N. S., Davie J. M. Serologic and topographic characterization of idiotopes on murine monoclonal anti-streptococcal group A carbohydrate antibodies. J Immunol. 1985 Feb;134(2):1065–1072. [PubMed] [Google Scholar]
  10. Harmon R. C., Stein N., Frelinger J. A. Monoclonal antibodies reactive with H-2 determinants. Immunogenetics. 1983;18(5):541–545. doi: 10.1007/BF00364395. [DOI] [PubMed] [Google Scholar]
  11. Jackson D. P., Percy D. H., Morris V. L. Characterization of murine hepatitis virus (JHM) RNA from rats with experimental encephalomyelitis. Virology. 1984 Sep;137(2):297–304. doi: 10.1016/0042-6822(84)90221-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kendall C., Ionescu-Matiu I., Dreesman G. R. Utilization of the biotin/avidin system to amplify the sensitivity of the enzyme-linked immunosorbent assay (ELISA). J Immunol Methods. 1983 Feb 11;56(3):329–339. doi: 10.1016/s0022-1759(83)80022-2. [DOI] [PubMed] [Google Scholar]
  13. Knobler R. L., Haspel M. V., Oldstone M. B. Mouse hepatitis virus type 4 (JHM strains). induced fatal central nervous system disease. I. genetic control and murine neuron as the susceptible site of disease. J Exp Med. 1981 Apr 1;153(4):832–843. doi: 10.1084/jem.153.4.832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Knobler R. L., Lampert P. W., Oldstone M. B. Virus persistence and recurring demyelination produced by a temperature-sensitive mutant of MHV-4. Nature. 1982 Jul 15;298(5871):279–280. doi: 10.1038/298279a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Knossow M., Daniels R. S., Douglas A. R., Skehel J. J., Wiley D. C. Three-dimensional structure of an antigenic mutant of the influenza virus haemagglutinin. Nature. 1984 Oct 18;311(5987):678–680. doi: 10.1038/311678a0. [DOI] [PubMed] [Google Scholar]
  16. Löve A., Rydbeck R., Kristensson K., Orvell C., Norrby E. Hemagglutinin-neuraminidase glycoprotein as a determinant of pathogenicity in mumps virus hamster encephalitis: analysis of mutants selected with monoclonal antibodies. J Virol. 1985 Jan;53(1):67–74. doi: 10.1128/jvi.53.1.67-74.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Makino S., Taguchi F., Hayami M., Fujiwara K. Characterization of small plaque mutants of mouse hepatitis virus, JHM strain. Microbiol Immunol. 1983;27(5):445–454. doi: 10.1111/j.1348-0421.1983.tb00603.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nakajima S., Kendal A. P. Antigenic drift in influenza A/USSR/90/77(H1N1) variants selected in vitro with monoclonal antibodies. Virology. 1981 Sep;113(2):656–662. doi: 10.1016/0042-6822(81)90194-x. [DOI] [PubMed] [Google Scholar]
  19. Portner A., Webster R. G., Bean W. J. Similar frequencies of antigenic variants in Sendai, vesicular stomatitis, and influenza A viruses. Virology. 1980 Jul 15;104(1):235–238. doi: 10.1016/0042-6822(80)90382-7. [DOI] [PubMed] [Google Scholar]
  20. Seif I., Coulon P., Rollin P. E., Flamand A. Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J Virol. 1985 Mar;53(3):926–934. doi: 10.1128/jvi.53.3.926-934.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Siddell S., Wege H., ter Meulen V. The structure and replication of coronaviruses. Curr Top Microbiol Immunol. 1982;99:131–163. doi: 10.1007/978-3-642-68528-6_4. [DOI] [PubMed] [Google Scholar]
  22. Sorensen O., Perry D., Dales S. In vivo and in vitro models of demyelinating diseases. III. JHM virus infection of rats. Arch Neurol. 1980 Aug;37(8):478–484. doi: 10.1001/archneur.1980.00500570026003. [DOI] [PubMed] [Google Scholar]
  23. Spriggs D. R., Fields B. N. Attenuated reovirus type 3 strains generated by selection of haemagglutinin antigenic variants. Nature. 1982 May 6;297(5861):68–70. doi: 10.1038/297068a0. [DOI] [PubMed] [Google Scholar]
  24. Stohlman S. A., Brayton P. R., Fleming J. O., Weiner L. P., Lai M. M. Murine coronaviruses: isolation and characterization of two plaque morphology variants of the JHM neurotropic strain. J Gen Virol. 1982 Dec;63(2):265–275. doi: 10.1099/0022-1317-63-2-265. [DOI] [PubMed] [Google Scholar]
  25. Stohlman S. A., Fleming J. O., Patton C. D., Lai M. M. Synthesis and subcellular localization of the murine coronavirus nucleocapsid protein. Virology. 1983 Oct 30;130(2):527–532. doi: 10.1016/0042-6822(83)90106-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Stohlman S. A., Weiner L. P. Chronic central nervous system demyelination in mice after JHM virus infection. Neurology. 1981 Jan;31(1):38–44. doi: 10.1212/wnl.31.1.38. [DOI] [PubMed] [Google Scholar]
  27. Stohlman S. A., Weiner L. P. Stability of neurotropic mouse hepatitis virus (JHM strain) during chronic infection of neuroblastoma cells. Arch Virol. 1978;57(1):53–61. doi: 10.1007/BF01315637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Stohlman S. A., Wisseman C. L., Jr, Eylar O. R., Silverman D. J. Dengue virus-induced modifications of host cell membranes. J Virol. 1975 Oct;16(4):1017–1026. doi: 10.1128/jvi.16.4.1017-1026.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sturman L. S., Holmes K. V. Proteolytic cleavage of peplomeric glycoprotein E2 of MHV yields two 90K subunits and activates cell fusion. Adv Exp Med Biol. 1984;173:25–35. doi: 10.1007/978-1-4615-9373-7_3. [DOI] [PubMed] [Google Scholar]
  30. Stähli C., Miggiano V., Stocker J., Staehelin T., Häring P., Takács B. Distinction of epitopes by monoclonal antibodies. Methods Enzymol. 1983;92:242–253. doi: 10.1016/0076-6879(83)92023-2. [DOI] [PubMed] [Google Scholar]
  31. Taguchi F., Siddell S. G., Wege H., ter Meulen V. Characterization of a variant virus selected in rat brains after infection by coronavirus mouse hepatitis virus JHM. J Virol. 1985 May;54(2):429–435. doi: 10.1128/jvi.54.2.429-435.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Talbot P. J., Salmi A. A., Knobler R. L., Buchmeier M. J. Topographical mapping of epitopes on the glycoproteins of murine hepatitis virus-4 (strain JHM): correlation with biological activities. Virology. 1984 Jan 30;132(2):250–260. doi: 10.1016/0042-6822(84)90032-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Webster R. G., Hinshaw V. S., Laver W. G. Selection and analysis of antigenic variants of the neuraminidase of N2 influenza viruses with monoclonal antibodies. Virology. 1982 Feb;117(1):93–104. doi: 10.1016/0042-6822(82)90510-4. [DOI] [PubMed] [Google Scholar]
  34. Wege H., Dörries R., Wege H. Hybridoma antibodies to the murine coronavirus JHM: characterization of epitopes on the peplomer protein (E2). J Gen Virol. 1984 Nov;65(Pt 11):1931–1942. doi: 10.1099/0022-1317-65-11-1931. [DOI] [PubMed] [Google Scholar]
  35. Wege H., Siddell S., ter Meulen V. The biology and pathogenesis of coronaviruses. Curr Top Microbiol Immunol. 1982;99:165–200. doi: 10.1007/978-3-642-68528-6_5. [DOI] [PubMed] [Google Scholar]
  36. Wege H., Watanabe R., ter Meulen V. Relapsing subacute demyelinating encephalomyelitis in rats during the course of coronavirus JHM infection. J Neuroimmunol. 1984 Aug;6(5):325–336. doi: 10.1016/0165-5728(84)90022-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Weiner L. P. Pathogenesis of demyelination induced by a mouse hepatitis. Arch Neurol. 1973 May;28(5):298–303. doi: 10.1001/archneur.1973.00490230034003. [DOI] [PubMed] [Google Scholar]
  38. Wiktor T. J., Koprowski H. Antigenic variants of rabies virus. J Exp Med. 1980 Jul 1;152(1):99–112. doi: 10.1084/jem.152.1.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Yewdell J. W., Gerhard W. Antigenic characterization of viruses by monoclonal antibodies. Annu Rev Microbiol. 1981;35:185–206. doi: 10.1146/annurev.mi.35.100181.001153. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES